-
Recombinant Mouse SHH in Developmental Translation
2026-09-16
A translational perspective on how Recombinant Mouse Sonic Hedgehog can help researchers connect morphogen biology with comparative urethral development, congenital malformation research, and more reproducible pathway assays.
-
GOB-38 in Elizabethkingia anophelis: Study Insights
2026-09-16
The reference study characterizes GOB-38, a B3 metallo-β-lactamase from Elizabethkingia anophelis, using recombinant expression, purification, substrate profiling, genomic analysis, and bacterial co-culture. Its broad hydrolysis profile and distinctive active-site residues provide a mechanistic framework for interpreting β-lactam resistance and assessing possible resistance interactions during co-infection.
-
WSP-5 for Live-Cell H2S Imaging
2026-09-15
WSP-5 transforms rapidly changing hydrogen sulfide signals into a bright, reaction-based readout for live cells, donor-release assays, and disease models. This workflow connects the diabetic cardiomyopathy literature with practical controls, imaging parameters, and troubleshooting strategies.
-
Bestatin (Ubenimex): Workflow and Applications
2026-09-15
Bestatin (Ubenimex) combines selective aminopeptidase inhibition with practical utility in enzyme assays, multidrug resistance studies, and plant chemical genetics. This workflow-focused guide covers stock preparation, cell and plant assay design, quantitative interpretation, and troubleshooting for more reproducible results.
-
BIIE 0246 in NPY Y2 Receptor Research
2026-09-14
BIIE 0246 is a selective neuropeptide Y Y2 receptor antagonist for separating Y2R signaling from the Y1R pathway implicated in adipose-neural cardiac studies. This article translates its reported presynaptic, gastrointestinal, feeding, and behavioral activity into practical assay workflows, controls, and troubleshooting decisions.
-
Nutlin-3a MDM2 Inhibitor Workflows for Cancer Research
2026-09-14
Build reproducible Nutlin-3a experiments around p53 stabilization, cell-cycle profiling, and apoptosis induction rather than relying on a single viability endpoint. The workflow also shows how to use this MDM2 inhibitor as a controlled perturbation alongside the miR-18a/ALOXE3 biology reported in glioblastoma research.
-
From T7 Transcription to Translational RNA Design
2026-09-13
A mechanistic and strategic guide to using defined T7-generated RNA as a foundation for epitranscriptomic studies, assay validation, RNA vaccine research, and translational decision-making.
-
Sodium Picosulfate Research Workflows
2026-09-12
Sodium Picosulfate offers a practical, controllable perturbation for intestinal transit, electrolyte handling, and liver-cell response studies. This guide connects bench assays with gut–liver–brain research while clearly separating established product characteristics from exploratory applications.
-
Dual Luciferase Reporter Gene System in ICC
2026-09-11
Use the Dual Luciferase Reporter Gene System to test enhancer activity, transcription-factor effects, and normalization-sensitive gene expression changes in mammalian cells. This workflow translates the ZNF263–ULK1 findings in intrahepatic cholangiocarcinoma into practical reporter experiments while adding troubleshooting guidance for scalable assays.
-
Sorafenib as a Time-Resolved Host-Directed Tool
2026-09-11
Sorafenib (BAY-43-9006) is more than a multikinase inhibitor: it can anchor experiments that connect RAF/MEK/ERK signaling, angiogenesis, and temporally resolved host responses. This article translates emerging EBOV transcriptomics into practical assay decisions while preserving Sorafenib’s value in oncology models.
-
JZL184: MAGL Inhibitor Workflows for Pain
2026-09-10
JZL184 gives researchers a direct way to elevate 2-AG and interrogate MAGL-dependent endocannabinoid signaling across synaptic, biochemical, and behavioral assays. This guide translates that mechanism into practical workflows for pain, affective-state, and CB1-linked neuroscience studies while emphasizing formulation control and orthogonal validation.
-
Simvastatin (Zocor): From Lipid Biology to Phenotypes
2026-09-09
Simvastatin (Zocor) is more than a cholesterol synthesis inhibitor: it is a useful probe for connecting HMG-CoA reductase biology with cell-state phenotypes. This article shows how machine-learning-aware assay design can distinguish mechanism, cellular context, and nonspecific toxicity.
-
Estrogen–Autophagy Axis in Perimenopausal Aging
2026-09-09
A 2026 study integrates NHANES data, perimenopausal mouse experiments, network pharmacology, and inhibitor-based validation to examine how estrogen protects the heart, aorta, and kidneys. Its central contribution is linking estradiol deficiency with multi-organ fibrosis through receptor-dependent autophagy signaling, while also defining important considerations for interpreting pharmacologic autophagy inhibition.
-
Phebestin: Nanomolar Aminopeptidase Inhibitor in Malaria
2026-09-08
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial compound active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its integrated parasite-stage, washout, computational, and mouse studies provide a useful framework for evaluating aminopeptidases as malaria drug targets while also defining important limits for translation.
-
Gentamycin Sulfate: Reliable Assay Workflows
2026-09-08
Learn how Gentamycin Sulfate, SKU A2514, can support controlled bacterial protein synthesis research, Gram-negative infection models, and antibiotic-resistance experiments without obscuring cell-viability results. The article connects product specifications with practical assay controls and recent evidence on carbapenem-resistant Enterobacter cloacae.